Rare diseases
Investigational molecules
Locations
Study of Lebrikizumab and Topical Corticosteroids for Children and Teens with Moderate-to-Severe Atopic Dermatitis
GermanyStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
GermanyEfficacy and Safety of Tirzepatide Versus Placebo in Adults with Type 1 Diabetes and Obesity or Overweight: A Phase 3 Randomized Controlled Trial
GermanyEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
GermanyStudy on Ritlecitinib for Adults and Adolescents with Nonsegmental Vitiligo
GermanyEfficacy and safety of eplontersen sodium plus ALXN2220 in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM)
GermanyGedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
GermanyJNJ-95597528 for Adults with Moderate to Severe Atopic Dermatitis
GermanyLong‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study
GermanyFaricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia
GermanyA study to evaluate the efficacy and safety of zenagamtide in people with obesity
GermanyA study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
